Acute myeloid leukaemia and Weight decrease neonatal

Summary:

Weight decrease neonatal is reported only by a few people with Acute myeloid leukaemia.

The study analyzes which people have Weight decrease neonatal with Acute myeloid leukaemia. It is created by eHealthMe based on 1 person who has Weight decrease neonatal and Acute myeloid leukaemia from the Food and Drug Administration (FDA), and is updated regularly.

What is Acute myeloid leukaemia?

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts) is found to be associated with 746 drugs and 1,180 conditions by eHealthMe. Check the latest studies of Acute myeloid leukaemia.

What is Weight decrease neonatal?

Weight decrease neonatal is found to be associated with 28 drugs and 113 conditions by eHealthMe. Check the latest studies of Weight decrease neonatal.

On Nov, 02, 2025

1 person who has Acute Myeloid Leukaemia and Weight Decrease Neonatal is studied.

Would you have Weight decrease neonatal when you have Acute myeloid leukaemia?

Common drugs taken by these people *:

Cytarabine: 1 person, 100.00%

Common symptoms for these people *:

Premature Baby: 1 person, 100.00%
Neonatal Hyponatraemia (low body temperature in neonate): 1 person, 100.00%
Hypoglycaemia Neonatal (deficiency of glucose in the bloodstream in neonatal): 1 person, 100.00%
Foetal Distress Syndrome (altered heart rate or rhythm and leading tocompromised blood flow or changes in blood chemistry of foetus): 1 person, 100.00%
Drug Exposure During Pregnancy: 1 person, 100.00%
Convulsion Neonatal (muscle contraction and relaxation rapidly in neonate): 1 person, 100.00%
Bone Marrow Failure: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weight decrease neonatal?

Check whether Weight decrease neonatal is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weight decrease neonatal and Acute myeloid leukaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.